APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Metformin Hydrochloride Sustained-release Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Metformin Hydrochloride Sustained-release Drug Industry Growth and Trends Forecast to 2032

22 December 2025117 pages

Choose your research edition.

Industry ResearchMetformin Hydrochloride Sustained-release Drug Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Metformin Hydrochloride Sustained-release Drug Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Metformin Hydrochloride Sustained-release Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metformin Hydrochloride Sustained-release Drug Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Metformin Hydrochloride Sustained-release Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Metformin Hydrochloride Sustained-release Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Metformin Hydrochloride Sustained-release Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Metformin Hydrochloride Sustained-release Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metformin Hydrochloride Sustained-release Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metformin Hydrochloride Sustained-release Drug include Apotex, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Viatris, Jingfeng Pharmaceutical Group, Beijing Shengyong Pharmaceutical, SinocorpPharma, Tianan Pharmaceutical and Jiangsu Deyuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Metformin Hydrochloride Sustained-release Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Metformin Hydrochloride Sustained-release Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metformin Hydrochloride Sustained-release Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metformin Hydrochloride Sustained-release Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Metformin Hydrochloride Sustained-release Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Metformin Hydrochloride Sustained-release Drug Market by Company

Apotex

Dr. Reddy's Laboratories

Sun Pharmaceutical Industries

Viatris

Jingfeng Pharmaceutical Group

Beijing Shengyong Pharmaceutical

SinocorpPharma

Tianan Pharmaceutical

Jiangsu Deyuan Pharmaceutical

Merck

Qingdao Huanghai Pharmaceutical

Shanghai Pharmaceuticals

CSPC

Teva Pharmaceuticals

Topfond Pharmaceutical

CTTQ

Chongqing Conquer Pharmaceutical

Metformin Hydrochloride Sustained-release Drug Segment by Type

Tablet

Capsule

Metformin Hydrochloride Sustained-release Drug Segment by Application

Hospital

Clinic

Other

Metformin Hydrochloride Sustained-release Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Hydrochloride Sustained-release Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metformin Hydrochloride Sustained-release Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Hydrochloride Sustained-release Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metformin Hydrochloride Sustained-release Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Metformin Hydrochloride Sustained-release Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Capsule Table 3. Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 5. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Metformin Hydrochloride Sustained-release Drug Price by Type (2021-2026) & (US$/unit) Table 9. Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2027-2032) & (k units) Table 10. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Metformin Hydrochloride Sustained-release Drug Price by Type (2027-2032) & (US$/unit) Table 14. North America Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 15. North America Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 17. Europe Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 21. Latin America Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Metformin Hydrochloride Sustained-release Drug Industry Trends Table 25. Metformin Hydrochloride Sustained-release Drug Industry Drivers Table 26. Metformin Hydrochloride Sustained-release Drug Industry Opportunities and Challenges Table 27. Metformin Hydrochloride Sustained-release Drug Industry Restraints Table 28. Global Metformin Hydrochloride Sustained-release Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Company (2021-2026) Table 30. Global Metformin Hydrochloride Sustained-release Drug Sales by Company (2021-2026) & (k units) Table 31. Global Metformin Hydrochloride Sustained-release Drug Sales Share by Company (2021-2026) Table 32. Global Metformin Hydrochloride Sustained-release Drug Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Metformin Hydrochloride Sustained-release Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Metformin Hydrochloride Sustained-release Drug Major Company Production Sites and Headquarters Table 35. Global Metformin Hydrochloride Sustained-release Drug Company, Product Type & Application Table 36. Global Metformin Hydrochloride Sustained-release Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Metformin Hydrochloride Sustained-release Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Metformin Hydrochloride Sustained-release Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Metformin Hydrochloride Sustained-release Drug Sales by Region (2021-2026) & (k units) Table 41. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Metformin Hydrochloride Sustained-release Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Metformin Hydrochloride Sustained-release Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Metformin Hydrochloride Sustained-release Drug Sales by Region (2027-2032) & (k units) Table 46. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Metformin Hydrochloride Sustained-release Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Metformin Hydrochloride Sustained-release Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 52. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Metformin Hydrochloride Sustained-release Drug Price by Application (2021-2026) & (US$/unit) Table 56. Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2027-2032) & (k units) Table 57. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Metformin Hydrochloride Sustained-release Drug Price by Application (2027-2032) & (US$/unit) Table 61. North America Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 62. North America Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 64. Europe Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 68. Latin America Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Apotex Company Information Table 72. Apotex Business Overview Table 73. Apotex Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Apotex Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 75. Apotex Recent Development Table 76. Dr. Reddy's Laboratories Company Information Table 77. Dr. Reddy's Laboratories Business Overview Table 78. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 80. Dr. Reddy's Laboratories Recent Development Table 81. Sun Pharmaceutical Industries Company Information Table 82. Sun Pharmaceutical Industries Business Overview Table 83. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 85. Sun Pharmaceutical Industries Recent Development Table 86. Viatris Company Information Table 87. Viatris Business Overview Table 88. Viatris Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Viatris Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 90. Viatris Recent Development Table 91. Jingfeng Pharmaceutical Group Company Information Table 92. Jingfeng Pharmaceutical Group Business Overview Table 93. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 95. Jingfeng Pharmaceutical Group Recent Development Table 96. Beijing Shengyong Pharmaceutical Company Information Table 97. Beijing Shengyong Pharmaceutical Business Overview Table 98. Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 100. Beijing Shengyong Pharmaceutical Recent Development Table 101. SinocorpPharma Company Information Table 102. SinocorpPharma Business Overview Table 103. SinocorpPharma Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. SinocorpPharma Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 105. SinocorpPharma Recent Development Table 106. Tianan Pharmaceutical Company Information Table 107. Tianan Pharmaceutical Business Overview Table 108. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 110. Tianan Pharmaceutical Recent Development Table 111. Jiangsu Deyuan Pharmaceutical Company Information Table 112. Jiangsu Deyuan Pharmaceutical Business Overview Table 113. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 115. Jiangsu Deyuan Pharmaceutical Recent Development Table 116. Merck Company Information Table 117. Merck Business Overview Table 118. Merck Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Merck Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 120. Merck Recent Development Table 121. Qingdao Huanghai Pharmaceutical Company Information Table 122. Qingdao Huanghai Pharmaceutical Business Overview Table 123. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 125. Qingdao Huanghai Pharmaceutical Recent Development Table 126. Shanghai Pharmaceuticals Company Information Table 127. Shanghai Pharmaceuticals Business Overview Table 128. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 130. Shanghai Pharmaceuticals Recent Development Table 131. CSPC Company Information Table 132. CSPC Business Overview Table 133. CSPC Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. CSPC Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 135. CSPC Recent Development Table 136. Teva Pharmaceuticals Company Information Table 137. Teva Pharmaceuticals Business Overview Table 138. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 140. Teva Pharmaceuticals Recent Development Table 141. Topfond Pharmaceutical Company Information Table 142. Topfond Pharmaceutical Business Overview Table 143. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 145. Topfond Pharmaceutical Recent Development Table 146. CTTQ Company Information Table 147. CTTQ Business Overview Table 148. CTTQ Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. CTTQ Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 150. CTTQ Recent Development Table 151. Chongqing Conquer Pharmaceutical Company Information Table 152. Chongqing Conquer Pharmaceutical Business Overview Table 153. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 155. Chongqing Conquer Pharmaceutical Recent Development Table 156. North America Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. North America Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026) & (k units) Table 158. North America Metformin Hydrochloride Sustained-release Drug Sales Market Share by Country (2021-2026) Table 159. North America Metformin Hydrochloride Sustained-release Drug Sales Forecast by Country (2027-2032) & (k units) Table 160. North America Metformin Hydrochloride Sustained-release Drug Sales Market Share Forecast by Country (2027-2032) Table 161. North America Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Metformin Hydrochloride Sustained-release Drug Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Metformin Hydrochloride Sustained-release Drug Market Share by Country (2021-2026) Table 164. North America Metformin Hydrochloride Sustained-release Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Metformin Hydrochloride Sustained-release Drug Market Share Forecast by Country (2027-2032) Table 166. Europe Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Europe Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026) & (k units) Table 168. Europe Metformin Hydrochloride Sustained-release Drug Sales Market Share by Country (2021-2026) Table 169. Europe Metformin Hydrochloride Sustained-release Drug Sales Forecast by Country (2027-2032) & (k units) Table 170. Europe Metformin Hydrochloride Sustained-release Drug Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Metformin Hydrochloride Sustained-release Drug Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Metformin Hydrochloride Sustained-release Drug Market Share by Country (2021-2026) Table 174. Europe Metformin Hydrochloride Sustained-release Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Metformin Hydrochloride Sustained-release Drug Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026) & (k units) Table 178. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Forecast by Country (2027-2032) & (k units) Table 180. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Share by Country (2021-2026) Table 184. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Share Forecast by Country (2027-2032) Table 186. Latin America Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Latin America Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026) & (k units) Table 188. Latin America Metformin Hydrochloride Sustained-release Drug Sales Market Share by Country (2021-2026) Table 189. Latin America Metformin Hydrochloride Sustained-release Drug Sales Forecast by Country (2027-2032) & (k units) Table 190. Latin America Metformin Hydrochloride Sustained-release Drug Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Metformin Hydrochloride Sustained-release Drug Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Metformin Hydrochloride Sustained-release Drug Market Share by Country (2021-2026) Table 194. Latin America Metformin Hydrochloride Sustained-release Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Metformin Hydrochloride Sustained-release Drug Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026) & (k units) Table 198. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Forecast by Country (2027-2032) & (k units) Table 200. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Share by Country (2021-2026) Table 204. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Metformin Hydrochloride Sustained-release Drug Distributors List Table 209. Metformin Hydrochloride Sustained-release Drug Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Metformin Hydrochloride Sustained-release Drug Image Figure 2. Global Metformin Hydrochloride Sustained-release Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metformin Hydrochloride Sustained-release Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Metformin Hydrochloride Sustained-release Drug Sales (2021-2032) & (k units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (k units) Figure 7. Capsule Image Figure 8. Global Capsule Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Metformin Hydrochloride Sustained-release Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Metformin Hydrochloride Sustained-release Drug Market Share by Type 2025 VS 2032 Figure 11. North America Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Metformin Hydrochloride Sustained-release Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Metformin Hydrochloride Sustained-release Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Metformin Hydrochloride Sustained-release Drug Market Share by Application 2025 VS 2032 Figure 31. North America Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Metformin Hydrochloride Sustained-release Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Metformin Hydrochloride Sustained-release Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Metformin Hydrochloride Sustained-release Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Metformin Hydrochloride Sustained-release Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Metformin Hydrochloride Sustained-release Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Metformin Hydrochloride Sustained-release Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Metformin Hydrochloride Sustained-release Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Metformin Hydrochloride Sustained-release Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Metformin Hydrochloride Sustained-release Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Metformin Hydrochloride Sustained-release Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Metformin Hydrochloride Sustained-release Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Metformin Hydrochloride Sustained-release Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Metformin Hydrochloride Sustained-release Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Metformin Hydrochloride Sustained-release Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Apotex
  • Dr. Reddy's Laboratories
  • Sun Pharmaceutical Industries
  • Viatris
  • Jingfeng Pharmaceutical Group
  • Beijing Shengyong Pharmaceutical
  • SinocorpPharma
  • Tianan Pharmaceutical
  • Jiangsu Deyuan Pharmaceutical
  • Merck
  • Qingdao Huanghai Pharmaceutical
  • Shanghai Pharmaceuticals
  • CSPC
  • Teva Pharmaceuticals
  • Topfond Pharmaceutical
  • CTTQ
  • Chongqing Conquer Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Metformin Hydrochloride Sustained-release Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Metformin Hydrochloride Sustained-release Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Metformin Hydrochloride Sustained-release Drug Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Capsule
  8. 1.4 Global Metformin Hydrochloride Sustained-release Drug Market Size by Type
  9. 1.4.1 Global Metformin Hydrochloride Sustained-release Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Metformin Hydrochloride Sustained-release Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Metformin Hydrochloride Sustained-release Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Metformin Hydrochloride Sustained-release Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Metformin Hydrochloride Sustained-release Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Metformin Hydrochloride Sustained-release Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Metformin Hydrochloride Sustained-release Drug Industry Trends
  2. 2.2 Metformin Hydrochloride Sustained-release Drug Industry Drivers
  3. 2.3 Metformin Hydrochloride Sustained-release Drug Industry Opportunities and Challenges
  4. 2.4 Metformin Hydrochloride Sustained-release Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Metformin Hydrochloride Sustained-release Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Metformin Hydrochloride Sustained-release Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Metformin Hydrochloride Sustained-release Drug Price (2021-2026)
  4. 3.4 Global Metformin Hydrochloride Sustained-release Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metformin Hydrochloride Sustained-release Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Metformin Hydrochloride Sustained-release Drug Company, Product Type & Application
  7. 3.7 Global Metformin Hydrochloride Sustained-release Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metformin Hydrochloride Sustained-release Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metformin Hydrochloride Sustained-release Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metformin Hydrochloride Sustained-release Drug Tier 1, Tier 2, and Tier 3
4 Metformin Hydrochloride Sustained-release Drug Regional Status and Outlook
  1. 4.1 Global Metformin Hydrochloride Sustained-release Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Metformin Hydrochloride Sustained-release Drug Historic Market Size by Region
  3. 4.2.1 Global Metformin Hydrochloride Sustained-release Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Metformin Hydrochloride Sustained-release Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Metformin Hydrochloride Sustained-release Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Metformin Hydrochloride Sustained-release Drug Forecasted Market Size by Region
  7. 4.3.1 Global Metformin Hydrochloride Sustained-release Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Metformin Hydrochloride Sustained-release Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Metformin Hydrochloride Sustained-release Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metformin Hydrochloride Sustained-release Drug by Application
  1. 5.1 Metformin Hydrochloride Sustained-release Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Metformin Hydrochloride Sustained-release Drug Market Size by Application
  6. 5.2.1 Global Metformin Hydrochloride Sustained-release Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Metformin Hydrochloride Sustained-release Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Metformin Hydrochloride Sustained-release Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Metformin Hydrochloride Sustained-release Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Metformin Hydrochloride Sustained-release Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Metformin Hydrochloride Sustained-release Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Apotex
  2. 6.1.1 Apotex Company Information
  3. 6.1.2 Apotex Business Overview
  4. 6.1.3 Apotex Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Apotex Metformin Hydrochloride Sustained-release Drug Product Portfolio
  6. 6.1.5 Apotex Recent Developments
  7. 6.2 Dr. Reddy's Laboratories
  8. 6.2.1 Dr. Reddy's Laboratories Company Information
  9. 6.2.2 Dr. Reddy's Laboratories Business Overview
  10. 6.2.3 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Product Portfolio
  12. 6.2.5 Dr. Reddy's Laboratories Recent Developments
  13. 6.3 Sun Pharmaceutical Industries
  14. 6.3.1 Sun Pharmaceutical Industries Company Information
  15. 6.3.2 Sun Pharmaceutical Industries Business Overview
  16. 6.3.3 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Product Portfolio
  18. 6.3.5 Sun Pharmaceutical Industries Recent Developments
  19. 6.4 Viatris
  20. 6.4.1 Viatris Company Information
  21. 6.4.2 Viatris Business Overview
  22. 6.4.3 Viatris Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Viatris Metformin Hydrochloride Sustained-release Drug Product Portfolio
  24. 6.4.5 Viatris Recent Developments
  25. 6.5 Jingfeng Pharmaceutical Group
  26. 6.5.1 Jingfeng Pharmaceutical Group Company Information
  27. 6.5.2 Jingfeng Pharmaceutical Group Business Overview
  28. 6.5.3 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Product Portfolio
  30. 6.5.5 Jingfeng Pharmaceutical Group Recent Developments
  31. 6.6 Beijing Shengyong Pharmaceutical
  32. 6.6.1 Beijing Shengyong Pharmaceutical Company Information
  33. 6.6.2 Beijing Shengyong Pharmaceutical Business Overview
  34. 6.6.3 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  36. 6.6.5 Beijing Shengyong Pharmaceutical Recent Developments
  37. 6.7 SinocorpPharma
  38. 6.7.1 SinocorpPharma Company Information
  39. 6.7.2 SinocorpPharma Business Overview
  40. 6.7.3 SinocorpPharma Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SinocorpPharma Metformin Hydrochloride Sustained-release Drug Product Portfolio
  42. 6.7.5 SinocorpPharma Recent Developments
  43. 6.8 Tianan Pharmaceutical
  44. 6.8.1 Tianan Pharmaceutical Company Information
  45. 6.8.2 Tianan Pharmaceutical Business Overview
  46. 6.8.3 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  48. 6.8.5 Tianan Pharmaceutical Recent Developments
  49. 6.9 Jiangsu Deyuan Pharmaceutical
  50. 6.9.1 Jiangsu Deyuan Pharmaceutical Company Information
  51. 6.9.2 Jiangsu Deyuan Pharmaceutical Business Overview
  52. 6.9.3 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  54. 6.9.5 Jiangsu Deyuan Pharmaceutical Recent Developments
  55. 6.10 Merck
  56. 6.10.1 Merck Company Information
  57. 6.10.2 Merck Business Overview
  58. 6.10.3 Merck Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck Metformin Hydrochloride Sustained-release Drug Product Portfolio
  60. 6.10.5 Merck Recent Developments
  61. 6.11 Qingdao Huanghai Pharmaceutical
  62. 6.11.1 Qingdao Huanghai Pharmaceutical Company Information
  63. 6.11.2 Qingdao Huanghai Pharmaceutical Business Overview
  64. 6.11.3 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  66. 6.11.5 Qingdao Huanghai Pharmaceutical Recent Developments
  67. 6.12 Shanghai Pharmaceuticals
  68. 6.12.1 Shanghai Pharmaceuticals Company Information
  69. 6.12.2 Shanghai Pharmaceuticals Business Overview
  70. 6.12.3 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product Portfolio
  72. 6.12.5 Shanghai Pharmaceuticals Recent Developments
  73. 6.13 CSPC
  74. 6.13.1 CSPC Company Information
  75. 6.13.2 CSPC Business Overview
  76. 6.13.3 CSPC Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 CSPC Metformin Hydrochloride Sustained-release Drug Product Portfolio
  78. 6.13.5 CSPC Recent Developments
  79. 6.14 Teva Pharmaceuticals
  80. 6.14.1 Teva Pharmaceuticals Company Information
  81. 6.14.2 Teva Pharmaceuticals Business Overview
  82. 6.14.3 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product Portfolio
  84. 6.14.5 Teva Pharmaceuticals Recent Developments
  85. 6.15 Topfond Pharmaceutical
  86. 6.15.1 Topfond Pharmaceutical Company Information
  87. 6.15.2 Topfond Pharmaceutical Business Overview
  88. 6.15.3 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  90. 6.15.5 Topfond Pharmaceutical Recent Developments
  91. 6.16 CTTQ
  92. 6.16.1 CTTQ Company Information
  93. 6.16.2 CTTQ Business Overview
  94. 6.16.3 CTTQ Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 CTTQ Metformin Hydrochloride Sustained-release Drug Product Portfolio
  96. 6.16.5 CTTQ Recent Developments
  97. 6.17 Chongqing Conquer Pharmaceutical
  98. 6.17.1 Chongqing Conquer Pharmaceutical Company Information
  99. 6.17.2 Chongqing Conquer Pharmaceutical Business Overview
  100. 6.17.3 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  102. 6.17.5 Chongqing Conquer Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Metformin Hydrochloride Sustained-release Drug Sales by Country
  2. 7.1.1 North America Metformin Hydrochloride Sustained-release Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Metformin Hydrochloride Sustained-release Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Metformin Hydrochloride Sustained-release Drug Market Size by Country
  6. 7.2.1 North America Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Metformin Hydrochloride Sustained-release Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Metformin Hydrochloride Sustained-release Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Metformin Hydrochloride Sustained-release Drug Sales by Country
  2. 8.1.1 Europe Metformin Hydrochloride Sustained-release Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Metformin Hydrochloride Sustained-release Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Metformin Hydrochloride Sustained-release Drug Market Size by Country
  6. 8.2.1 Europe Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Metformin Hydrochloride Sustained-release Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Metformin Hydrochloride Sustained-release Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales by Country
  2. 9.1.1 Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Metformin Hydrochloride Sustained-release Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Metformin Hydrochloride Sustained-release Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Metformin Hydrochloride Sustained-release Drug Sales by Country
  2. 10.1.1 South America Metformin Hydrochloride Sustained-release Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Metformin Hydrochloride Sustained-release Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Metformin Hydrochloride Sustained-release Drug Market Size by Country
  6. 10.2.1 South America Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Metformin Hydrochloride Sustained-release Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Metformin Hydrochloride Sustained-release Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales by Country
  2. 11.1.1 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Metformin Hydrochloride Sustained-release Drug Value Chain Analysis
  2. 12.1.1 Metformin Hydrochloride Sustained-release Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Metformin Hydrochloride Sustained-release Drug Production Mode & Process
  7. 12.2 Metformin Hydrochloride Sustained-release Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Metformin Hydrochloride Sustained-release Drug Distributors
  10. 12.2.3 Metformin Hydrochloride Sustained-release Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst